Boston Scientific Corp. Stock Sheds 3.4%, Underperforms Peers
Dow Jones2026/08/26 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Boston Scientific Corp. shed 3.4% to $48.17 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,675.70 and the Dow Jones Industrial Average falling 0.2% to 53,463.88.
Boston Scientific Corp. closed 56.0% short of its 52-week high of $109.50, which the company achieved on September 9th.
The stock underperformed when compared to some of its peers, as Abbott Laboratories fell 1.7% to $114.10, Medtronic PLC rose 1.0% to $92.02, and Stryker Corp. fell 0.28% to $329.67.
Trading volume totaled 36.0 million, compared to the 50-day average of 20.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 26, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
T1 Energy wins Norway rezoning approval for Giga Arctic data center development
BonTerra posts June 30, 2026 half-year loss as exploration spending increases, company says
NeuroOne reports successful large-animal procedures using next-generation StereoCED platform
Myriad Genetics to present at Wells Fargo Healthcare Conference